CLINICAL TRIALS PROFILE FOR NAMENDA
✉ Email this page to a colleague
All Clinical Trials for NAMENDA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00120874 ↗ | Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training | Completed | Fisher Center for Alzheimer's Research Foundation | Phase 4 | 2006-08-01 | The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease. |
NCT00120874 ↗ | Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training | Completed | Forest Laboratories | Phase 4 | 2006-08-01 | The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease. |
NCT00120874 ↗ | Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training | Completed | New York University School of Medicine | Phase 4 | 2006-08-01 | The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NAMENDA
Condition Name
Clinical Trial Locations for NAMENDA
Trials by Country
Clinical Trial Progress for NAMENDA
Clinical Trial Phase
Clinical Trial Sponsors for NAMENDA
Sponsor Name